PRESIDENT HAS SERVED AS A REVIEWER FOR THE FELLOWSHIP: CELL BIOLOGY, DEVELOPMENTAL BIOLOGY, AND BIOENGINEERING [F05] STUDY SECTION FOR THE NIH

PDX Pharma’s President has served as a reviewer for the Fellowship: Cell Biology, Developmental Biology, and Bioengineering [F05] Study Section for the National Institute of Health (NIH) held on February 28, 2017 – March 1, 2017.